重组人血小板生成素用于原发免疫性血小板减少症维持治疗的有效性和安全性——多中心临床研究

OBJECTIVE: To evaluate the efficacy and safety of maintenance therapy with reduced dose of rhTPO in the patients with primary immune thrombocytopenia (ITP) who attained stable platelet (PLT) counts after daily administration of rhTPO. METHODS: Treatment was started with a daily administration of rhT...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2017
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354185/
https://www.ncbi.nlm.nih.gov/pubmed/28565735
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.05.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354185/
https://www.ncbi.nlm.nih.gov/pubmed/28565735
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.05.005

Ejemplares similares